Aaron Davis is Co-Founder and Chief Executive Officer of Boxer Capital, LLC. In 2005, after joining Tavistock Group as Portfolio Manager, Mr. Davis scaled Tavistock Group’s public healthcare investing activities and formed Boxer Capital. Mr. Davis leads the firm’s research team, deal structuring, and portfolio management.
Mr. Davis is currently Chairman of the Board of CiVi Biopharma and is a Member of the Board of Directors of iTeos Therapeutics, Mirati Therapeutics, Odonate Therapeutics, Sojournix, Inc., and Tango Therapeutics.